Andrew Adams

Managing Partner at Oak HC/FT

Co-Founder & Managing Partner
2014 - Current
Active Investments: August Bioservices, Curana Health, DispatchHealth, Eating Recovery Center, Galileo, Infusion for Health, Marathon Health, Noom, Precision Medicine Group, Reveleer, Rialtic, Unified Women's Healthcare, US HealthVest, Veda Data Prior Investments: American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (NASDAQ: CLRT; acquired by GE Healthcare), Core Informatics (acquired by Thermo Fisher Scientific), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), Independent Living Systems, LDI Integrated Pharmacy Services (acquired by Diplomat Pharmacy), Limeade (ASX: LME), Maestro Health (acquired by AXA Group), NetSpend Corporation (NASDAQ: NTSP; acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by Clayton, Dubilier & Rice), Therapy Brands (acquired by KKR), United BioSource (acquired by Medco Health Solutions), One Medical Group (NASDAQ: ONEM)